![GlaxoSmithKline will invest US$41mn to create an open lab to research non-communicable diseases in Africa. (Image source: Maxwell Hamilton/Flickr)](/images/GSK_Maxwell_Hamilton_Flickr.jpg)
GlaxoSmithKline will invest US$41mn to create an open lab to research non-communicable diseases in Africa. (Image source: Maxwell Hamilton/Flickr)
Pharmaceutical major GlaxoSmithKline (GSK) is to invest US$216mn in Africas healthcare sector, which includes the development of a lab, expansion of manufacturing facilities and training of community healthcare professionals